EDGAR Filing Documents for 0001213900-24-069344

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001213900-24-069344

Filing Date

2024-08-15

Accepted

2024-08-15 07:28:44

Documents

160

Period of Report

2024-03-31

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	ea0210595-20f_lakeshore.htm iXBRL	20-F	3389680
2	AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE REGISTRANT AS	ea021059501ex1-1_lakeshore.htm	EX-1.1	241297
3	DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE U.S. EXCHANGE ACT	ea021059501ex2-1_lakeshore.htm	EX-2.1	42276
4	REGISTRANT'S SPECIMEN ORDINARY SHARE CERTIFICATE	ea021059501ex2-2_lakeshore.htm	EX-2.2	3375
5	REGISTRANT'S SPECIMEN WARRANT CERTIFICATE	ea021059501ex2-3_lakeshore.htm	EX-2.3	23239
6	FORM OF EMPLOYMENT AGREEMENT BETWEEN THE REGISTRANT AND ITS EXECUTIVE OFFICERS	ea021059501ex4-1_lakeshore.htm	EX-4.1	73047
7	SHARE PURCHASE AGREEMENT, DATED AS OF FEBRUARY 7, 2024, BETWEEN THE REGISTRANT A	ea021059501ex4-3_lakeshore.htm	EX-4.3	128824
8	2020 SHARE INCENTIVE PLAN	ea021059501ex4-4_lakeshore.htm	EX-4.4	135597
9	2024 SHARE INCENTIVE PLAN	ea021059501ex4-5_lakeshore.htm	EX-4.5	116163
10	LIST OF PRINCIPAL SUBSIDIARIES	ea021059501ex8-1_lakeshore.htm	EX-8.1	4921
11	CODE OF BUSINESS CONDUCT AND ETHICS OF THE REGISTRANT	ea021059501ex11-1_lakeshore.htm	EX-11.1	87372
12	INSIDER TRADING POLICY	ea021059501ex11-2_lakeshore.htm	EX-11.2	51320
13	CERTIFICATION	ea021059501ex12-1_lakeshore.htm	EX-12.1	9586
14	CERTIFICATION	ea021059501ex12-2_lakeshore.htm	EX-12.2	10314
15	CERTIFICATION	ea021059501ex13-1_lakeshore.htm	EX-13.1	4653
16	CERTIFICATION	ea021059501ex13-2_lakeshore.htm	EX-13.2	4545
17	CONSENT OF WEI, WEI & CO., LLP. - INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	ea021059501ex15-1_lakeshore.htm	EX-15.1	3477
18	CONSENT OF JINGTIAN & GONGCHENG	ea021059501ex15-2_lakeshore.htm	EX-15.2	3577
19	CONSENT OF MAPLES AND CALDER (HONG KONG) LLP	ea021059501ex15-3_lakeshore.htm	EX-15.3	5010
20	INCENTIVE COMPENSATION RECOUPMENT POLICY	ea021059501ex97-1_lakeshore.htm	EX-97.1	35708
21	GRAPHIC	image_001.jpg	GRAPHIC	98786
22	GRAPHIC	image_002.jpg	GRAPHIC	455654
23	GRAPHIC	image_003.jpg	GRAPHIC	19426
24	GRAPHIC	image_004.jpg	GRAPHIC	12867
25	GRAPHIC	image_005.jpg	GRAPHIC	9218
26	GRAPHIC	image_006.jpg	GRAPHIC	15393
27	GRAPHIC	image_007.jpg	GRAPHIC	13215
28	GRAPHIC	image_008.jpg	GRAPHIC	12719
29	GRAPHIC	image_009.jpg	GRAPHIC	16228
30	GRAPHIC	image_010.jpg	GRAPHIC	15394
31	GRAPHIC	image_011.jpg	GRAPHIC	24319
32	GRAPHIC	image_012.jpg	GRAPHIC	25234
33	GRAPHIC	image_013.jpg	GRAPHIC	12671
34	GRAPHIC	image_014.jpg	GRAPHIC	64249
35	GRAPHIC	image_015.jpg	GRAPHIC	18949
36	GRAPHIC	image_016.jpg	GRAPHIC	28627
37	GRAPHIC	image_017.jpg	GRAPHIC	21602
38	GRAPHIC	image_018.jpg	GRAPHIC	10668
39	GRAPHIC	image_019.jpg	GRAPHIC	15977
40	GRAPHIC	image_020.jpg	GRAPHIC	8908
41	GRAPHIC	image_021.jpg	GRAPHIC	22053
42	GRAPHIC	image_022.jpg	GRAPHIC	19717
43	GRAPHIC	fin_001.jpg	GRAPHIC	8601
44	GRAPHIC	fin_002.jpg	GRAPHIC	9314
45	GRAPHIC	fin_003.jpg	GRAPHIC	75874
46	GRAPHIC	ex15-1_001.jpg	GRAPHIC	18435
47	GRAPHIC	ex15-1_002.jpg	GRAPHIC	25745
48	GRAPHIC	ex15-3_001.jpg	GRAPHIC	2756
	Complete submission text file	0001213900-24-069344.txt		16749990

Data Files

Seq	Description	Document	Type	Size
49	XBRL SCHEMA FILE	lsb-20240331.xsd	EX-101.SCH	110677
50	XBRL CALCULATION FILE	lsb-20240331_cal.xml	EX-101.CAL	84808
51	XBRL DEFINITION FILE	lsb-20240331_def.xml	EX-101.DEF	503811
52	XBRL LABEL FILE	lsb-20240331_lab.xml	EX-101.LAB	881762
53	XBRL PRESENTATION FILE	lsb-20240331_pre.xml	EX-101.PRE	518980
163	EXTRACTED XBRL INSTANCE DOCUMENT	ea0210595-20f_lakeshore_htm.xml	XML	1709330

Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629

Business Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629 17327133678

LakeShore Biopharma Co., Ltd. (Filer) CIK: 0001946399 (see all company filings)